A UHPLC–MS/MS-based method for the simultaneous monitoring of eight antiblastic drugs in plasma and urine of exposed healthcare workers
Autor: | Marine Pascal Pingeon, Maria Alfieri, Valeria Conti, Valentina Manzo, Alfonso Vietri, Fabrizio Dal Piaz, Bruno Charlier, Antonietta Finelli, Marianna Romano, Viviana Izzo, Amelia Filippelli, Elena Bloise |
---|---|
Rok vydání: | 2018 |
Předmět: |
Antiblastic drugs
Health Personnel Clinical Biochemistry Pharmaceutical Science Antineoplastic Agents Urine Pharmacology 01 natural sciences Uhplc ms ms Analytical Chemistry Plasma 03 medical and health sciences 0302 clinical medicine Pharmacokinetics Tandem Mass Spectrometry Adverse health effect Occupational Exposure Drug Discovery Health care medicine Chemotherapy Humans LC-MS/MS Biological monitoring Workers exposure Chromatography High Pressure Liquid Spectroscopy business.industry Chemistry 010401 analytical chemistry University hospital 030210 environmental & occupational health 0104 chemical sciences Irinotecan Antineoplastic Drugs business Environmental Monitoring medicine.drug |
Zdroj: | Journal of Pharmaceutical and Biomedical Analysis. 154:245-251 |
ISSN: | 0731-7085 |
DOI: | 10.1016/j.jpba.2018.03.024 |
Popis: | Exposure of healthcare workers to anticancer drugs requires the combined action of environmental and biological monitoring to assess the effective level of exposure to these chemicals, to improve awareness and to avoid adverse health effects on this category of workers. Cancer chemotherapeutic drugs show different mechanisms of action due to diverse chemical structures; consequently, they differ in hydrophobicity, pharmacokinetics and pharmacodynamics. Therefore, the appearance, accumulation and elimination of each of these molecules in body fluids and tissues might be extremely variable; this prompts the need for a rapid and versatile analytical protocol for the biological monitoring of possible exposure of workers involved in the manipulation, administration and disposal of cancer chemotherapeutic drugs. In this paper we describe the development, optimization and validation of a UHPLC–MS/MS method for the simultaneous quasi-quantitative analysis of eight widely used antineoplastic drugs, which can be used for the analysis of both urine and blood samples. This methodology was applied to the biological monitoring of healthcare workers exposed to different extents to antiblastic drugs at the University Hospital “San Giovanni di Dio e Ruggi d’Aragona” in Salerno (Italy), and allowed to identify two subjects exposed to irinotecan out of a total of fifteen workers analyzed. |
Databáze: | OpenAIRE |
Externí odkaz: |